<DOC>
	<DOCNO>NCT02141087</DOCNO>
	<brief_summary>This open label multi-center program allow patient US IPF access treatment pirfenidone .</brief_summary>
	<brief_title>Expanded Access Program ( EAP ) : Allow Patients US With Idiopathic Pulmonary Fibrosis Access Pirfenidone</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<criteria>1 . Clinical radiographic diagnosis IPF include presence usual interstitial pneumonia ( UIP ) pattern possible UIP pattern historical HRCT ( ATS 2011 ) . 2 . % FVC ≥ 50 % % DLCO ≥ 30 % base either historical pulmonary function test obtain 30 day prior screen test obtain screen . 3 . Able understand importance adherence program treatment ( pirfenidone ) protocol , willing follow program requirement , include concomitant medication restriction , throughout program . 4 . Able understand sign write informed consent form . A patient meet follow criterion exclude program : 1 . Is receive investigational agent ( defined drug approve marketing indication US ) ; prior use pirfenidone permit . 2 . Has receive fluvoxamine therapy ≤ 28 day prior first dose program treatment ( pirfenidone ) PIPF031 , unable unwilling avoid fluvoxamine duration program . 3 . Has know contraindication use pirfenidone , specifically : Hypersensitivity active substance drug product excipients Severe hepatic impairment include end stage liver disease Severe renal impairment ( CrCl &lt; 30 mL/min ) include end stage renal disease require dialysis 4 . History cigarette smoking within 3 month prior completion screen unwilling avoid tobacco product throughout program . 5 . Known explanation interstitial lung disease IPF , include limited radiation , drug toxicity , sarcoidosis , hypersensitivity pneumonitis , bronchiolitis obliterans organize pneumonia , human immunodeficiency virus ( HIV ) infection , viral hepatitis , cancer . 6 . History clinically significant environmental exposure know cause pulmonary fibrosis ( PF ) , include limited drug ( amiodarone ) , asbestos , beryllium , radiation , domestic bird . 7 . Pregnancy lactation . Women childbearing capacity require negative serum pregnancy test treatment must agree maintain highly effective contraception practice abstinence use least two method birth control date consent end participation program . If abstinence practice , one two method birth control hormonal contraceptive ( e.g. , oral contraceptive spermicide ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>